Login / Signup

The impact of rifaximin on inflammation and metabolism in alcoholic hepatitis: A randomized clinical trial.

Nina KimerMads MeldgaardOle HambergThit Mynster KronborgAllan M LundHolger Jon MøllerFlemming BendtsenHenriette Ytting
Published in: PloS one (2022)
Rifaximin does not alter inflammation or metabolism in patients with AH.
Keyphrases
  • oxidative stress
  • irritable bowel syndrome
  • liver injury
  • drug induced